Trials / Withdrawn
WithdrawnNCT04666701
Efficacy and Safety of Escócia Association in the Treatment of Acute Pain
National, Multicenter, Randomized, Double-blind, Triple-dummy, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Escócia Association in the Treatment of Acute Pain
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- EMS · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of Escócia association in adults with acute pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Escócia association | Escócia association tablet |
| OTHER | Placebo Ketorolac | Placebo Ketorolac tablet |
| OTHER | Placebo Scopolamine | Placebo Scopolamine dragee |
| DRUG | Ketorolac Tromethamine | Ketorolac tablet |
| DRUG | Scopolamine | Scopolamine dragee |
| OTHER | Placebo Escócia association | Placebo Escócia association tablet |
Timeline
- Start date
- 2023-02-01
- Primary completion
- 2025-02-01
- Completion
- 2025-06-01
- First posted
- 2020-12-14
- Last updated
- 2023-09-08
Source: ClinicalTrials.gov record NCT04666701. Inclusion in this directory is not an endorsement.